Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores-Reference-Cited by-同舟云学术

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

Published:2019-11 Issue:5 Volume:157 Page:1264-1278.e4
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ioannou George N.,Beste Lauren A.,Green Pamela K.,Singal Amit G.,Tapper Elliot B.,Waljee Akbar K.,Sterling Richard K.,Feld Jordan J.,Kaplan David E.,Taddei Tamar H.,Berry Kristin

Funder

AbbVie

Gilead

Valeant

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies;Morgan;Ann Intern Med,2013

2. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis;Singal;Clin Gastroenterol Hepatol,2010

3. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents;Kanwal;Gastroenterology,2017

4. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study;Singer;Aliment Pharmacol Ther,2018

5. Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma [published online ahead of print September 5, 2017]. J Hepatol https://doi.org/10.1016/j.jhep.2017.08.030.

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs;Annals of Hepatology;2024-09

2. Towards risk-based surveillance for HCC after HCV cure?;Hepatology;2024-08-13

3. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

4. Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation;Alimentary Pharmacology & Therapeutics;2024-08-07

5. Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study;Cancers;2024-08-01